GeneDx Holdings (NASDAQ: WGS) saw its stock rise over 8% following a strong second-quarter earnings report that revealed nearly $103 million in revenue, a 49% year-over-year increase, driven by a 69% surge in exome and genome testing sales. This performance stood in stark contrast to the S&P 500’s modest 0.3% decline.
Want More Context? 🔎
Old Dominion (ODFL) Q2 2025 Earnings Transcript
Old Dominion Freight Line (NASDAQ: ODFL) emphasizes a disciplined pricing strategy amid ongoing pressure on volumes and revenue. Despite short-term profitability challenges due to competitive pressures and industry overcapacity, the company continues to invest strategically in network capacity, technology, and workforce to prepare for long-term demand recovery. Want More Context? 🔎
Read more